California Academy of Family Physicians (CAFP)
MAY 14, 2025
Medi-Cal Minimum Medical Loss Ratio – Increases the minimum medical loss ratio for managed care plans, commencing January 1, 2026. Proposed Changes to Prescription Drug Coverage Prescription Drug Utilization Management- Implements utilization management and prior authorization for prescription drugs.
The Clinical Problem Solvers
DECEMBER 16, 2020
Our guests explain how we can incorporate race-conscious medicine in clinical settings, medical education, and biomedical/epidemiological research to responsibly recognize and address the harms of racial inequality. These factors include a high-protein diet, muscle mass, creatinine generation, and certain medications. link] Tsai J.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Annals of Family Medicine
NOVEMBER 20, 2024
Objective: Identify patient, provider, and healthcare process and utilization factors associated with rates of secondary acceptance of the HPV vaccine. Existing research on secondary acceptance has focused on demographics and initial declination with little evidence around factors associated with increased rates of secondary acceptance.
FDA Law Blog
SEPTEMBER 5, 2023
Houck — Scheduling Criteria Under the Controlled Substances Act (“CSA”) Schedule I: • High potential for abuse; • No currently accepted medical use in treatment in the U.S.; and • Lack of accepted safety for use under medical supervision. DEA and HHS last considered rescheduling cannabis in 2016. 21 U.S.C. § 53,688 (Aug.
The Motivated MD
SEPTEMBER 19, 2024
A study by Johns Hopkins in 2016 found that medical errors may potentially be the third leading cause of death nationwide. ’ Though it often does not come with the attending salary, medical trainees are getting paid to perform a service, and hospitals provide retirement plans to these individuals.
FDA Law Blog
JUNE 7, 2021
This sentence was included in the 2016 approval of Exondys 51 for Duchenne muscular dystrophy and the 2018 approval of Andexxa for reversal of anticoagulation therapy. be “reasonably likely to predict” ultimate clinical benefit). Yesterday’s approval of Aduhelm helped answer that.
GeriPal
FEBRUARY 15, 2024
Accreditation In support of improving patient care, UCSF Office of CME is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Eric: Yeah.
Expert insights. Personalized for you.
204 
Let's personalize your content